Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.
about
Combination HIV prevention: significance, challenges, and opportunitiesCombination implementation for HIV prevention: moving from clinical trial evidence to population-level effectsCombination prevention: new hope for stopping the epidemicHow do HIV-negative individuals in sub-Saharan Africa change their sexual risk behaviour upon learning their serostatus? A systematic reviewHarnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosisHIV treatment as prevention: considerations in the design, conduct, and analysis of cluster randomized controlled trials of combination HIV preventionStructural approaches for prevention of sexually transmitted HIV in general populations: definitions and an operational approachClinical uncertainties, health service challenges, and ethical complexities of HIV "test-and-treat": a systematic reviewCombining epidemiological and genetic networks signifies the importance of early treatment in HIV-1 transmissionHIV treatment as prevention: contradictory perspectives from dynamic mathematical modelsUniversal access to HIV treatment versus universal 'test and treat': transmission, drug resistance & treatment costsEarly identification of HIV: empirical support for jail-based screeningElimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison studyExpanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis.The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa.A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.It's a Process: Reactions to HIV Diagnosis and Engagement in HIV Care among High-Risk Heterosexuals.Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South AfricaThe dual impact of antiretroviral therapy and sexual behaviour changes on HIV epidemiologic trends in Uganda: a modelling studyShould we try to eliminate HIV epidemics by using a 'Test and Treat' strategy?HIV testing and engagement in care among highly vulnerable female sex workers: implications for treatment as prevention models.Modelling sexual transmission of HIV: testing the assumptions, validating the predictions.Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.How HIV treatment could result in effective preventionWill circumcision provide even more protection from HIV to women and men? New estimates of the population impact of circumcision interventionsHIV treatment as prevention: the key to an AIDS-free generation.Late entry into HIV care: lessons from Brazil, 2003 to 2006.Antiretroviral therapy for tuberculosis control in nine African countries.HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South AfricaPlasma HIV viral rebound following protocol-indicated cessation of ART commenced in primary and chronic HIV infectionContact with HIV prevention services highest in gay and bisexual men at greatest risk: cross-sectional survey in ScotlandUsing plasma viral load to guide antiretroviral therapy initiation to prevent HIV-1 transmission.Community viral load and CD4 count distribution among people living with HIV in a South African Township: implications for treatment as preventionWhy the proportion of transmission during early-stage HIV infection does not predict the long-term impact of treatment on HIV incidenceUnderstanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community.The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco.Rethinking prevention of HIV type 1 infection.
P2860
Q22252603-A51430DC-895F-42B8-A52C-113097F63E5CQ24610019-36CAA50D-9EDC-41BE-9937-B756A03CF8B7Q24630559-7E1F5CD8-C8E0-4EB0-BFB3-89447A8C3144Q26741027-F21E7F6F-0A1E-4228-90BF-290A275AC77CQ26828443-260397B3-9050-4B10-AC0E-C00A54868085Q26853353-3DDF46F5-2A91-4798-A60C-466B176072A6Q27008538-16F757D9-BCEE-41DA-B9FA-5A185A280156Q27026742-E2466D6D-213A-4B0E-9A52-D1CF117D1D39Q27316777-A01457A0-6D90-4A67-BAAB-8AF13A4EBBB0Q28080917-8CED244F-7D78-4A92-8C66-88201972B0BAQ28483485-95FD045C-4483-4937-A827-192847AA72C0Q28483957-1A58AF92-8C9D-44ED-BD31-A35C4D09EA67Q28534568-A4B0194F-860C-4AAC-8AA8-94B14F2A4E06Q28732123-A5FABB53-33B2-4C41-A68C-C0B44EFFF1D8Q30514758-215F6259-4102-4576-BA6A-FC8F44742D6DQ31026449-15023F6F-3C7A-4EB8-9E66-3E0F68855AF8Q33608640-20D9FA2E-8F8D-4E90-8426-3A13276C1023Q33611645-907E68EC-DFAC-4005-AA48-C62194141BD2Q33626374-5D250607-49DA-4DCD-9C1D-FECEE9B47268Q33653802-04222B1B-CF32-42DF-B9F8-955138996CC0Q33747742-F3B40B65-DFE5-46DD-8387-31D7280AB1EDQ33956748-BFB6BD6B-4BE8-481B-A72E-A907FFD76333Q33956969-10C1F817-A351-49DA-B2A1-9A8D3C442D11Q34063967-7CFDC5B8-68FF-40A2-AB22-8822DAEA4BB2Q34071168-FA695A73-F6B2-4D9E-91C7-F93CDD29CEE9Q34081339-622A81DF-09E8-4906-9D36-7235D6F15A75Q34090397-3D45119B-740A-4AB6-A540-6889DF46C787Q34145112-F248FFC4-19DA-462A-847E-45AE61DEEC1FQ34154129-FC54771B-F196-4558-8841-627255031F86Q34244259-A2DC70A3-3EA6-4231-8315-9D5A409DDE0BQ34320245-40BB3EDA-8A8F-4C76-9F99-837C65AE9C02Q34339465-C3CBAC20-E617-4254-9971-F5E18072209DQ34405543-408CEA1C-C4A6-4BCE-8995-379D4F38BD1DQ34500070-5E73F3D9-5F8C-44E6-91DE-945BDC6B1E09Q34515366-622E5677-3EDC-4261-BC3B-3378FFB081BBQ34519553-3150F97F-EB6C-4BF5-867A-C9B765C7B407Q34526461-955CA578-965C-4282-AE70-7369BF69C6E2Q34571215-E090393A-6A31-416A-A725-FF47DD4AE7D5Q34756819-8B180BC0-1A50-4A83-96F8-F963B8C16C93Q34767070-B5B2BE4F-2EDB-4576-937E-48D1CBC3CCE6
P2860
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.
@ast
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.
@en
type
label
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.
@ast
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.
@en
prefLabel
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.
@ast
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.
@en
P2860
P1433
P1476
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings.
@en
P2093
Geoff P Garnett
Timothy B Hallett
P2860
P304
P356
10.1097/QAD.0B013E32833433FE
P407
P50
P577
2010-03-01T00:00:00Z